Solana, E, Martinez-Heras, E, Montal, V, Vilaplana, E, Lopez-Soley, E, Radua, J, Sola-Valls, N, Montejo, C, Blanco, Y, Pulido-Valdeolivas, I, Sepulveda, M, Andorra, M, Berenguer, J, Villoslada, P, Martinez-Lapiscina, EH, Prados, F, Saiz, A, Fortea, J, Llufriu, S. Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients. Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-96132-x. PMID:34413373. IF:4.997(Q2/3D).

de Asua, DR, Mayer, MA, Ortega, MD, Borrel, JM, Bermejo, TD, Gonzalez-Lamuno, D, Manso, C, Moldenhauer, F, Carmona-Iragui, M, Huls, A, Sherman, SL, Strydom, A, de la Torre, R, Dierssen, M, Spanish Trisomy 21 Res Soc COVID-1. Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome. Journal of Clinical Medicine. 2021; 10(16)DOI:10.3390/jcm10163748. PMID:34442043. IF:4.964(Q2/4D).

Carmona-Iragui, M, Alcolea, D, Barroeta, I, Videla, L, Munoz, L, Van Pelt, KL, Schmitt, FA, Lightner, DD, Koehl, LM, Jicha, G, Sacco, S, Mircher, C, Pape, SE, Hithersay, R, Clare, ICH, Holland, AJ, Nubling, G, Levin, J, Zaman, SH, Strydom, A, Rebillat, AS, Head, E, Blesa, R, Lleo, A, Fortea, J. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study. LANCET NEUROLOGY. 2021; 20(8)DOI:10.1016/S1474-4422(21)00129-0. PMID:34302785. IF:59.935(Q1/1D).

Shi, L, Buckley, NJJ, Bos, I, Engelborghs, S, Sleegers, K, Frisoni, GB, Wallin, A, Lleo, A, Popp, J, Martinez-Lage, P, Legido-Quigley, C, Barkhof, F, Zetterberg, H, Visser, PJ, Bertram, L, Lovestone, S, Nevado-Holgado, AJ. Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies. Frontiers in Aging Neuroscience. 2021; 13DOI:10.3389/fnagi.2021.712545. PMID:34366831. IF:5.702(Q1/3D).